Left Atrial Enhancement Correlates With Myocardial Conduction Velocity in Patients With Persistent Atrial Fibrillation
Overview
Authors
Affiliations
Background: Conduction velocity (CV) heterogeneity and myocardial fibrosis both promote re-entry, but the relationship between fibrosis as determined by left atrial (LA) late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-CMRI) and CV remains uncertain.
Objective: Although average CV has been shown to correlate with regional LGE-CMRI in patients with persistent AF, we test the hypothesis that a localized relationship exists to underpin LGE-CMRI as a minimally invasive tool to map myocardial conduction properties for risk stratification and treatment guidance.
Method: 3D LA electroanatomic maps during LA pacing were acquired from eight patients with persistent AF following electrical cardioversion. Local CVs were computed using triads of concurrently acquired electrograms and were co-registered to allow correlation with LA wall intensities obtained from LGE-CMRI, quantified using normalized intensity (NI) and image intensity ratio (IIR). Association was evaluated using multilevel linear regression.
Results: An association between CV and LGE-CMRI intensity was observed at scales comparable to the size of a mapping electrode: -0.11 m/s per unit increase in NI ( < 0.001) and -0.96 m/s per unit increase in IIR ( < 0.001). The magnitude of this change decreased with larger measurement area. Reproducibility of the association was observed with NI, but not with IIR.
Conclusion: At clinically relevant spatial scales, comparable to area of a mapping catheter electrode, LGE-CMRI correlates with CV. Measurement scale is important in accurately quantifying the association of CV and LGE-CMRI intensity. Importantly, NI, but not IIR, accounts for changes in the dynamic range of CMRI and enables quantitative reproducibility of the association.
The impact of atrial voltage and conduction velocity phenotypes on atrial fibrillation recurrence.
Silva Cunha P, Laranjo S, Monteiro S, Portugal G, Guerra C, Rocha A Front Cardiovasc Med. 2024; 11:1427841.
PMID: 39736879 PMC: 11683111. DOI: 10.3389/fcvm.2024.1427841.
Atrial Fibrillation and Underlying Structural and Electrophysiological Heterogeneity.
Iwamiya S, Ihara K, Nitta G, Sasano T Int J Mol Sci. 2024; 25(18).
PMID: 39337682 PMC: 11432636. DOI: 10.3390/ijms251810193.
Artificial intelligence applied in cardiovascular disease: a bibliometric and visual analysis.
Zhang J, Zhang J, Jin J, Jiang X, Yang L, Fan S Front Cardiovasc Med. 2024; 11:1323918.
PMID: 38433757 PMC: 10904648. DOI: 10.3389/fcvm.2024.1323918.
Macheret F, Bifulco S, Scott G, Kwan K, Chahine Y, Afroze T JACC Clin Electrophysiol. 2023; 9(10):2149-2162.
PMID: 37656099 PMC: 10909381. DOI: 10.1016/j.jacep.2023.06.015.
Ohguchi S, Inden Y, Yanagisawa S, Fujita R, Yasuda K, Katagiri K BMC Cardiovasc Disord. 2022; 22(1):457.
PMID: 36319975 PMC: 9628089. DOI: 10.1186/s12872-022-02881-6.